Purchase Order 75N92018P00098

<p>The National Heart Lung and Blood Institute awarded a purchase order to The Emmes Company, LLC on May 9, 2018, for administrative assistance to the Institute's Data Safety and Monitoring Board, with a ceiling value of $104,242.43. The order carries no set-aside designation and is priced on a time-and-materials basis. Work is performed in Bethesda, Maryland, with an ultimate completion date of June 2, 2019.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to The Emmes Company, LLC on September 7, 2017, for protocol monitoring and data management support services, with a ceiling value of $62,074.41. Work is performed in Bethesda, Maryland, under firm fixed price. The order is set to complete on May 6, 2018.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to The Emmes Company, LLC on May 9, 2018 for protocol monitoring and data management services, with a ceiling value of $230,671.30. The order is priced on a time-and-materials basis with an ultimate completion date of August 15, 2019. Work is performed in Rockville, Maryland.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $121,652 time and materials delivery order to The Emmes Company LLC. The delivery order is for regulatory support services under Task Area 2 of an indefinite delivery/indefinite quantity contract vehicle. Specifically, the contractor will provide assistance with investigational new drug and investigational device exemption submissions from July 1, 2022 through June 30,...

The Emmes Company LLC has been awarded a $83,280.58 time-and-materials delivery order from the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to provide regulatory support for investigational new drug and investigational device exemption submissions. Specifically, Task Order 2 under an unspecified vehicle will fund clinical trial services including assistance with IND and IDE applications to the Food and Drug Administration. The...

The Emmes Company LLC has been awarded a $125,723.05 time-and-materials delivery order from the Department of Health and Human Services National Institutes of Health National Heart, Lung and Blood Institute to provide Protocol Monitoring and Data Management Support Services. Under this task order issued against an existing indefinite delivery contract vehicle, Emmes will monitor study progress and maintain patient databases to support the National Heart, Lung and Blood Institute's clinical...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $46,082.82 time-and-materials delivery order to The Emmes Company LLC under an unidentified contract vehicle. This Task Order 3 calls for The Emmes Company LLC to provide statistical expertise and data safety and monitoring board support to the funding agency. The period of performance is July 1, 2020 through July 31, 2021. No set-aside designation was applied to this...

<p>The National Human Genome Research Institute awarded a purchase order to The Emmes Company, LLC for $22,460.00 on April 24, 2019, with an ultimate completion date of May 30, 2019. Performance is at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific procurement scope is not detailed in the source.</p>

This is a federal contract award to The Emmes Company LLC, a global clinical research organization, by the National Heart Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). The contract, valued at $42,466.50, is for clinical research support and collaboration for NHGRI protocols, specifically focused on regulatory support for Investigational New Drug (IND) and Investigational Device Exemption (IDE) submissions. The contract is a Delivery Order under a Time and...

<p>The National Human Genome Research Institute issued a delivery order to The Emmes Company, LLC on July 1, 2026, for regulatory support for IND and IDE submissions, with a ceiling value of $33,691.</p> <p>Place of performance is Bethesda, MD. The order is priced on a time-and-materials basis and is scheduled for completion by June 30, 2027. No set-aside was used.</p>